US7241876B2
(en)
|
1996-01-11 |
2007-07-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
US6828431B1
(en)
*
|
1999-04-09 |
2004-12-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
US6943236B2
(en)
|
1997-02-25 |
2005-09-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US20030185830A1
(en)
*
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6329505B1
(en)
|
1997-02-25 |
2001-12-11 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
US6818751B1
(en)
|
1997-08-01 |
2004-11-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
US6894146B1
(en)
|
1997-02-25 |
2005-05-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6630305B1
(en)
|
1999-11-12 |
2003-10-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7202342B1
(en)
|
1999-11-12 |
2007-04-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6620922B1
(en)
|
1997-02-25 |
2003-09-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6657056B2
(en)
|
1997-02-25 |
2003-12-02 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6800746B2
(en)
|
1997-02-25 |
2004-10-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6465611B1
(en)
|
1997-02-25 |
2002-10-15 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6759515B1
(en)
|
1997-02-25 |
2004-07-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7517952B1
(en)
|
1997-02-25 |
2009-04-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
JP3981416B2
(ja)
|
1997-04-10 |
2007-09-26 |
ユニバーシティ メディカル センター ナイメーヘン |
Pca3タンパク質、pca3遺伝子、及びこれらの用途
|
US6365369B1
(en)
|
1998-04-01 |
2002-04-02 |
Human Genome Sciences, Inc. |
Prostate specific secreted protein
|
US6861215B1
(en)
|
1998-05-21 |
2005-03-01 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging prostate cancer
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
EP1086223B1
(en)
|
1998-06-01 |
2009-07-29 |
Agensys, Inc. |
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US7037667B1
(en)
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
CA2344552A1
(en)
*
|
1998-10-02 |
2000-04-13 |
Urogenesys, Inc. |
Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
US6528054B1
(en)
*
|
1998-12-28 |
2003-03-04 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
KR20020026418A
(ko)
*
|
1999-04-09 |
2002-04-10 |
길리스 스티브 |
유방암을 치료 및 진단하기 위한 조성물 및 방법
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
WO2000065067A2
(en)
*
|
1999-04-23 |
2000-11-02 |
University Of Washington |
Prostate-specific polynucleotides, polypeptides and their methods of use
|
AU5416700A
(en)
*
|
1999-05-20 |
2000-12-12 |
Fahri Saatcioglu |
Differentially expressed genes in prostate cancer
|
AU6158700A
(en)
*
|
1999-07-13 |
2001-01-30 |
Corixa Corporation |
Vaccine
|
ATE321857T1
(de)
|
1999-09-29 |
2006-04-15 |
Diagnocure Inc |
Pca3 mrna in gutartigen und bösartigen prostatageweben
|
WO2001023577A2
(en)
*
|
1999-09-30 |
2001-04-05 |
Institut Pasteur |
Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences
|
AU7994200A
(en)
*
|
1999-10-04 |
2001-05-10 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
US7208280B2
(en)
|
1999-10-05 |
2007-04-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
JP4272376B2
(ja)
*
|
1999-10-05 |
2009-06-03 |
アジェンシス,インコーポレイテッド |
前立腺ガンにおいてアップレギュレートされるgタンパク質結合レセプターおよびその使用
|
US6790631B1
(en)
|
1999-10-05 |
2004-09-14 |
Agensys, Inc. |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
WO2001025446A1
(en)
*
|
1999-10-07 |
2001-04-12 |
Schering Aktiengesellschaft |
Dna encoding prost 07 polypeptide
|
EP1230364A2
(en)
*
|
1999-11-12 |
2002-08-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US20020048777A1
(en)
|
1999-12-06 |
2002-04-25 |
Shujath Ali |
Method of diagnosing monitoring, staging, imaging and treating prostate cancer
|
MXPA02006934A
(es)
*
|
2000-01-14 |
2003-01-28 |
Corixa Corp |
Composiciones y metodos para la terapia y diagnostico de cancer de prostata.
|
WO2001059110A2
(en)
*
|
2000-02-08 |
2001-08-16 |
Agensys, Inc. |
34p3d7: a tissue specific protein highly expressed in prostate cancer
|
WO2001060860A2
(en)
*
|
2000-02-17 |
2001-08-23 |
Millennium Predictive Medicine, Inc. |
Genes differentially expressed in human prostate cancer and their use
|
US20030165831A1
(en)
*
|
2000-03-21 |
2003-09-04 |
John Lee |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
|
US7611892B2
(en)
|
2000-03-24 |
2009-11-03 |
President And Fellows Of Harvard College |
Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
JP2004504808A
(ja)
*
|
2000-03-27 |
2004-02-19 |
コリクサ コーポレイション |
前立腺癌の治療及び診断のための組成物及び方法
|
GB0015736D0
(en)
*
|
2000-06-27 |
2000-08-16 |
Smithkline Beecham Biolog |
Vaccine
|
GB0015722D0
(en)
*
|
2000-06-27 |
2000-08-16 |
Smithkline Beecham Sa |
Vaccine
|
PT2266603E
(pt)
|
2000-10-18 |
2012-11-02 |
Glaxosmithkline Biolog Sa |
Vacinas tumorais
|
US7048931B1
(en)
|
2000-11-09 |
2006-05-23 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
EP1343912A2
(en)
|
2000-11-28 |
2003-09-17 |
Wyeth |
Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
JP2004526425A
(ja)
|
2000-11-28 |
2004-09-02 |
ワイス |
前立腺癌の診断および治療に有用なfkbp核酸およびポリペプチドの発現分析
|
EP1573024A4
(en)
|
2001-04-10 |
2007-08-29 |
Agensys Inc |
NUCLEIC ACIDS AND SUITABLE PROTEINS SUITABLE FOR THE TREATMENT AND EVIDENCE OF VARIOUS CANCER DISEASES
|
JP2005504513A
(ja)
*
|
2001-05-09 |
2005-02-17 |
コリクサ コーポレイション |
前立腺癌の治療及び診断のための組成物及び方法
|
US6897024B2
(en)
|
2001-05-31 |
2005-05-24 |
Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen |
Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
|
ES2537074T3
(es)
|
2001-09-06 |
2015-06-02 |
Agensys, Inc. |
Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
CA2480811A1
(en)
*
|
2002-04-01 |
2003-10-16 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
|
AU2003250828A1
(en)
*
|
2002-06-11 |
2003-12-22 |
Glaxo Group Limited |
Immunogenic compositions comprising a xenogenic prostate protein p501s
|
MXPA04012443A
(es)
*
|
2002-06-11 |
2005-04-19 |
Glaxosmithkline Biolog Sa |
Composiciones inmunogenicas.
|
WO2004016733A2
(en)
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
JP4824540B2
(ja)
|
2003-02-07 |
2011-11-30 |
ダイアノキュアー インク. |
サンプル中の前立腺癌を検出する方法
|
WO2005014642A2
(en)
|
2003-07-21 |
2005-02-17 |
Transgene S.A. |
Novel multifunctional cytokines
|
NZ550816A
(en)
|
2004-04-22 |
2009-12-24 |
Agensys Inc |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
CA2491067A1
(en)
|
2004-12-24 |
2006-06-24 |
Stichting Katholieke Universiteit |
Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
|
CA2622295C
(en)
|
2005-09-12 |
2019-01-15 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
US9957569B2
(en)
|
2005-09-12 |
2018-05-01 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
WO2008016111A1
(en)
|
2006-08-04 |
2008-02-07 |
Ajinomoto Co., Inc. |
Method for evaluation of lung cancer, lung cancer evaluation apparatus, lung cancer evaluation method, lung cancer evaluation system, lung cancer evaluation program, and recording medium
|
PT2486938T
(pt)
|
2006-09-26 |
2018-06-12 |
Infectious Disease Res Inst |
Composição para vacina contendo adjuvante sintético
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
EP2061814B1
(en)
|
2006-10-27 |
2012-06-06 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
WO2008075662A1
(ja)
|
2006-12-21 |
2008-06-26 |
Ajinomoto Co., Inc. |
乳癌の評価方法、ならびに乳癌評価装置、乳癌評価方法、乳癌評価システム、乳癌評価プログラムおよび記録媒体
|
JP5746811B2
(ja)
|
2006-12-21 |
2015-07-08 |
味の素株式会社 |
大腸癌の評価方法、ならびに大腸癌評価装置、大腸癌評価方法、大腸癌評価システム、大腸癌評価プログラムおよび記録媒体
|
CA2692793C
(en)
|
2007-07-06 |
2014-05-20 |
The Regents Of The University Of Michigan |
Mipol1-etv1 gene rearrangements
|
WO2009020521A2
(en)
|
2007-08-03 |
2009-02-12 |
The Brigham And Women's Hospital, Inc. |
Identification and treatment of estrogen responsive prostate tumors
|
KR100976218B1
(ko)
|
2008-05-26 |
2010-08-17 |
한국표준과학연구원 |
비행시간이차이온질량분광법을 이용한 질병의 진단 방법,질병 지표의 스크린 방법, 및 질병 지표
|
KR101821551B1
(ko)
*
|
2008-06-20 |
2018-01-25 |
아지노모토 가부시키가이샤 |
전립선 질환의 평가 방법
|
BRPI0912462B1
(pt)
*
|
2008-08-05 |
2022-03-22 |
Toray Industries, Inc |
Uso de um agente indutor de imunidade, uso de um polipeptídeo e uso de um vetor recombinante
|
DK2325648T3
(da)
|
2008-08-05 |
2014-07-28 |
Toray Industries |
Fremgangsmåde til detektering af cancer
|
RU2498819C2
(ru)
|
2008-08-05 |
2013-11-20 |
Торэй Индастриз, Инк. |
Фармацевтическая композиция для лечения и профилактики злокачественных опухолей
|
US8778621B2
(en)
*
|
2009-05-12 |
2014-07-15 |
Koninklijke Philips N.V. |
Phosphodiesterase 4D7 as marker for malignant, hormone-sensitive prostate cancer
|
TWI494125B
(zh)
|
2009-06-05 |
2015-08-01 |
Infectious Disease Res Inst |
合成的葡萄吡喃糖基脂質佐劑
|
JP5800817B2
(ja)
|
2009-09-17 |
2015-10-28 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
前立腺癌における再発性遺伝子融合
|
MX342291B
(es)
|
2010-02-04 |
2016-09-23 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
|
AU2011211682B2
(en)
|
2010-02-04 |
2015-08-13 |
Toray Industries, Inc. |
Pharmaceutical composition for treating and/or preventing cancer
|
JP5742714B2
(ja)
|
2010-02-04 |
2015-07-01 |
東レ株式会社 |
癌の治療及び/又は予防用医薬組成物
|
ES2691738T3
(es)
|
2010-02-04 |
2018-11-28 |
Toray Industries, Inc. |
Agente farmacéutico para el tratamiento y/o la prevención de cáncer
|
PL2532743T3
(pl)
|
2010-02-04 |
2015-09-30 |
Toray Industries |
Kompozycja farmaceutyczna do leczenia i/lub zapobiegania raka
|
US8945556B2
(en)
|
2010-11-19 |
2015-02-03 |
The Regents Of The University Of Michigan |
RAF gene fusions
|
AU2012217723A1
(en)
|
2011-02-15 |
2013-08-29 |
Immune Design Corp. |
Methods for enhancing immunogen specific immune responses by vectored vaccines
|
AU2012243039B2
(en)
|
2011-04-08 |
2017-07-13 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
PT2741085T
(pt)
|
2011-08-04 |
2017-06-30 |
Toray Industries |
Método para a deteção de cancro prancreático
|
HUE039219T2
(hu)
|
2011-08-04 |
2018-12-28 |
Toray Industries |
Gyógyászati készítmény rák kezelésére és/vagy megelõzésére
|
AU2012290949B2
(en)
|
2011-08-04 |
2017-03-02 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
|
PT2740795T
(pt)
|
2011-08-04 |
2017-01-09 |
Toray Industries |
Composição de fármaco para o tratamento e/ou a prevenção de cancro
|
US9180188B2
(en)
|
2011-08-04 |
2015-11-10 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
AU2012290957B2
(en)
|
2011-08-04 |
2017-04-20 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
AU2012290955B2
(en)
|
2011-08-04 |
2017-04-27 |
Toray Industries, Inc. |
Drug composition for cancer treatment and/or prevention
|
PL2811981T3
(pl)
|
2012-02-07 |
2019-09-30 |
Infectious Disease Research Institute |
Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
|
JP6187255B2
(ja)
|
2012-02-21 |
2017-08-30 |
東レ株式会社 |
癌の治療及び/又は予防用医薬組成物
|
KR102005786B1
(ko)
|
2012-02-21 |
2019-07-31 |
도레이 카부시키가이샤 |
암의 치료 및/또는 예방용 의약 조성물
|
CA2865020C
(en)
|
2012-02-21 |
2021-01-26 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
EP2818481B1
(en)
|
2012-02-21 |
2019-08-07 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
PT2832366T
(pt)
|
2012-03-30 |
2018-01-25 |
Toray Industries |
Composição farmacêutica para o tratamento e/ou a prevenção de cancro de vesícula biliar
|
BR112014023937A2
(pt)
|
2012-03-30 |
2018-04-17 |
Toray Industries |
composição farmacêutica, agente farmacêutico de combinação e método de tratamento
|
EA034351B1
(ru)
|
2012-05-16 |
2020-01-30 |
Иммьюн Дизайн Корп. |
Трехкомпонентная вакцина против впг-2 и способы ее применения
|
WO2013176916A1
(en)
*
|
2012-05-25 |
2013-11-28 |
Roman Galetto |
Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells
|
EP2876447B1
(en)
|
2012-07-19 |
2019-11-20 |
Toray Industries, Inc. |
Method for detecting cancer
|
CN104471403B
(zh)
|
2012-07-19 |
2017-03-01 |
东丽株式会社 |
癌的检测方法
|
SG10201701866QA
(en)
|
2012-09-11 |
2017-04-27 |
Oncotherapy Science Inc |
Ube2t peptides and vaccines containing the same
|
WO2014066443A1
(en)
|
2012-10-23 |
2014-05-01 |
Emory University |
Gm-csf and il-4 conjugates, compositions, and methods related thereto
|
BR112015025709A2
(pt)
|
2013-04-18 |
2017-07-18 |
Immune Design Corp |
monoterapia com gla para uso em tratamento de câncer
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
MX360671B
(es)
|
2013-08-09 |
2018-11-13 |
Toray Industries |
Composición farmacéutica para el tratamiento y/o prevención del cáncer.
|
PT3089754T
(pt)
|
2013-12-31 |
2021-07-23 |
Infectious Disease Res Inst |
Formulações de vacina de dose única
|
JP2017522312A
(ja)
|
2014-07-15 |
2017-08-10 |
イミューン デザイン コーポレイション |
Tlr4アゴニストアジュバント及びレンチウイルスベクターを用いたプライム・ブーストレジメン
|
JOP20200228A1
(ar)
*
|
2015-12-21 |
2017-06-16 |
Novartis Ag |
تركيبات وطرق لخفض تعبير البروتين tau
|
CN108472350A
(zh)
*
|
2016-01-08 |
2018-08-31 |
瓦西博迪公司 |
新表位rna癌症疫苗
|
CA3020542A1
(en)
|
2016-04-11 |
2017-10-19 |
Board Of Regents, The University Of Texas System |
Methods and compositions for detecting single t cell receptor affinity and sequence
|
CA3023672A1
(en)
|
2016-05-16 |
2017-11-23 |
Infectious Disease Research Institute |
Pegylated liposomes and methods of use
|
US11344619B2
(en)
|
2016-05-16 |
2022-05-31 |
Access To Advanced Health Institute |
Formulation containing TLR agonist and methods of use
|
AU2017273650B2
(en)
|
2016-06-01 |
2022-08-18 |
Access To Advanced Health Institute |
Nanoalum particles containing a sizing agent
|
SG11201909218RA
(en)
|
2017-04-03 |
2019-11-28 |
Hoffmann La Roche |
Antibodies binding to steap-1
|
MX2019015076A
(es)
|
2017-06-15 |
2020-08-03 |
Infectious Disease Res Inst |
Portadores lípidos nanoestructurados y emulsiones estables y usos de los mismos.
|
CA3078223A1
(en)
|
2017-09-08 |
2019-03-14 |
Infectious Disease Research Institute |
Liposomal formulations comprising saponin and methods of use
|
JP2022512921A
(ja)
*
|
2018-11-07 |
2022-02-07 |
アコーオス インコーポレイテッド |
有毛細胞の分化を誘導する組成物及び方法
|
CN111000858B
(zh)
*
|
2019-05-10 |
2021-04-09 |
常州市第二人民医院 |
Nupr1抑制剂在制备膀胱癌治疗药物中的用途
|
MX2021014363A
(es)
|
2019-05-25 |
2022-02-21 |
Infectious Disease Res Inst |
Composicion y metodo para secar por pulverizacion una emulsion de vacuna adyuvante.
|
CN111968751B
(zh)
*
|
2020-06-29 |
2021-10-19 |
金电联行(北京)信息技术有限公司 |
一种使用多基线校正模型的传染病趋势预测方法与系统
|
CA3174411A1
(en)
|
2020-09-04 |
2022-03-10 |
Ryan M. Kramer |
Co-lyophilized rna and nanostructured lipid carrier
|
WO2022051024A1
(en)
|
2020-09-04 |
2022-03-10 |
Infectious Disease Research Institute |
Genetically-adjuvanted rna vaccines
|
JP2024501949A
(ja)
|
2020-12-23 |
2024-01-17 |
アクセス ツー アドバンスト ヘルス インスティチュート |
ソラネソールワクチンアジュバント及びその調製方法
|
WO2024052882A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|